20.3200.00% ( 0.000 )
Delay Closed: Nov 16, 16:08:00Overview
CAM EU QLTY HDG (3165)
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Index. Th...
- Open
- 20.320
- High
- 20.320
- Low
- 20.320
- Prev. Close
- 20.320
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- -59.66%
- Amplitude
- 0.00%
- 52wk High
- 20.460
- Volume Ratio
- 0.00
- Turnover Ratio
- --
- 52wk Low
- 16.970
- Dividend YieldTTM
- 1.67%
- DividendTTM
- 0.34
- NAV
- --
- NAV Date
- --
- Disc/Prem Rate
- --
- Total Issued
- 5.70M
- Assets
- 115.82M
- Min lot size
- 200
- Currency
- HKD
News
benzinga_article · AstraZeneca Secures Dual Rare Disease and Bladder Cancer Approvals Across US, Europe
Yicai · China Adds Record 51 Innovative Drugs to Public Medical Insurance Catalog
Pharmaceutical Technology · Sofinnova Partners backs European life sciences sector with €725M raise
Pharmaceutical Technology · AstraZeneca secures FDA approval for Imfinzi combo in MIBC
rttnews · AstraZeneca: Alexion's Klygefa Gets EU Approval To Treat Adults With Generalised Myasthenia Gravis
London Stock Exchange · REG - AstraZeneca PLC - Baxfendy recommended for approval in the EU
